Addition of the human interferon β scaffold attachment region to retroviral vector backbones increases the level of in vivo transgene expression among progeny of engrafted human hematopoietic stem cells

Human Gene Therapy

Volumn 11, Issue 14, 2000, Pages 2039-2050

  Murray, L ^b   Travis, M ^a   Luens Abitorabi, K ^a   Olsson, K ^b   Plavec, I ^b   Forestell, S ^b   Hanania, E G ^b   Hill, B ^b  

^a NOVARTIS PHARMA AG   (Switzerland)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CD34 ANTIGEN;

ADOLESCENT; ANIMAL CELL; ARTICLE; BONE; CELL SUBPOPULATION; EXPRESSION VECTOR; FLUORESCENCE ACTIVATED CELL SORTER; GENE EXPRESSION; GENE TARGETING; GENETIC MANIPULATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MOLONEY LEUKEMIA ONCOVIRUS; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; RETROVIRUS; TRANSGENE;

ANIMALS; ANTIGENS, CD34; CELL LINE; CELL SEPARATION; FLOW CYTOMETRY; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEMATOPOIETIC STEM CELLS; HUMANS; INTERFERON-BETA; MICE; MICE, MUTANT STRAINS; MICE, SCID; MOLONEY MURINE LEUKEMIA VIRUS; POLYMERASE CHAIN REACTION; RETROVIRIDAE; TRANSDUCTION, GENETIC; TRANSGENES;

ANIMALIA; MOLONEY MURINE LEUKEMIA VIRUS; MURINAE; ONCOVIRINAE; UNIDENTIFIED RETROVIRUS;

EID: 0034692441     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340050143453     Document Type: Article

References (37)

1. Scaffold attachment region-mediated enhancement of retroviral vector expression in primary T cells
2. Effect of scaffold attachment region on transgene expression in retrovirus vector transduced primary T cells and macrophages
3. Isolation of a candidate human hematopoietic stem-cell population
4. Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells
5. Effects of retroviral-mediated MDR1 expression on hematopoietic stem cell self-renewal and differentiation in culture
6. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells
7. Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo
8. Multiple modifications in cis elements of the long terminal repeat of retroviral vectors lead to increased expression and decreased DNA methylation in embryonic carcinoma cells
9. Sustained gene expression in retrovirally transduced, engrafting human hematopoietic stem cells and their lympho-myeloid progeny
10. Chromosomal loop anchorage of the kappa immunoglobulin gene occurs next to the enhancer in a region containing topoisomerase II sites
11. Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine
12. Human beta interferon scaffold attachment region inhibits de novo methylation and confers long-term, copy number-dependent expression to a retroviral vector
13. Retroviral end-point titer is not predictive of gene transfer efficiency: Implications for vector production
14. Novel retroviral packaging cell lines: Complementary tropisms and improved vector production for efficient gene transfer
15. Improved quantitation of minimal residual disease in multiple myeloma using real-time PCR and plasmid-DNA CDR-III standards
16. + hematopoietic cells
17. Transplantable myeloproliferative disease in mice by an interleukin 6 retrovirus
18. Versatile retroviral vectors for potential use in gene therapy
19. Initiation of protein synthesis by internal entry of ribosomes into 5' nontranslated region of encephalomyocarditis virus RNA in vivo
20. Implantation and maintenance of functional human marrow in SCID-hu mice
21. Retrovirus mediated gene expression in hematopoietic cells correlates inversely with growth factor stimulation
22. - cells with preserved ability to engraft in SCID-hu bone
23. Functional dissection of the HIV-1 Rev trans-dominant repressor of Rev function
24. Improved retroviral vectors for gene transfer and expression
25. Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors
26. - subpopulation from mobilized peripheral blood
27. + cells into rapid division
28. Optimization of retroviral gene transduction of mobilized primitive hematopoietic progenitors by using thrombopoietin, Flt3 and Kit ligands and RetroNectin culture
29. Stem cell gene therapy, position effects and chromatin insulators
30. Novel real-time t(11;14) and t(14;18) PCR assays provide sensitive and quantitative assessments of minimal residual disease (MRD)
31. Sustained high level reconstitution of the hematopoietic system by pre-selected hematopoietic cells expressing a transduced cell-surface antigen
32. High transdominant RevM10 protein levels are required to inhibition HIV-1 replication in cell lines and primary T cells: Implication for gene therapy of AIDS
33. A novel human amphotropic packaging cell line: High titer, complement resistance, and improved safety
34. Quantitative assessment of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cells engrafted in nonobese diabetic/severe combined immunodeficient mice
35. Isolation and expression of an altered mouse dihydrofolate reductase cDNA
36. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay
37. + subset following cell division ex vivo